Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Leiomyosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Leiomyosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leiomyosarcoma - Drugs In Development, 2021, provides...
July 2021
827 pages
Measles (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Measles (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Measles - Drugs In Development, 2021, provides an...
July 2021
53 pages
Melanocortin Receptor 4 - Drugs In Development, 2021
US$ 3,500.00
Melanocortin Receptor 4 - Drugs In Development, 2021 SUMMARY Melanocortin Receptor 4 (MC4R) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by...
July 2021
88 pages
Myc Proto Oncogene Protein - Drugs In Development, 2021
US$ 3,500.00
Myc Proto Oncogene Protein - Drugs In Development, 2021 SUMMARY Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes cl...
July 2021
69 pages
Neutropenia (Hematology) - Drugs In Development, 2021
US$ 2,000.00
Neutropenia (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia - Drugs In Development, 2021, provides an...
July 2021
150 pages
Nociceptin Receptor - Drugs In Development, 2021
US$ 3,500.00
Nociceptin Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Nociceptin Receptor - Drugs In Development, 2021'; Nociceptin Receptor (Kappa Type 3 Opioid Recepto...
July 2021
58 pages
Oligodendroglioma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Oligodendroglioma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Drugs In Development, 2021, pr...
July 2021
201 pages
Orexin Receptor Type 1 - Drugs In Development, 2021
US$ 3,500.00
Orexin Receptor Type 1 - Drugs In Development, 2021 SUMMARY Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Orexin receptor type 1 (Ox1R or OX1) is a protein that is encoded by the HCR...
July 2021
85 pages
Orexin Receptor Type 2 - Drugs In Development, 2021
US$ 3,500.00
Orexin Receptor Type 2 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Orexin Receptor Type 2 - Drugs In Development, 2021'; Orexin Receptor Type 2 (Hypocretin Recepto...
July 2021
97 pages
Osteosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Osteosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteosarcoma - Drugs In Development, 2021, provides an...
July 2021
1205 pages
Pancreatic Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Pancreatic Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Drugs In Development, 2021, pr...
July 2021
5249 pages
Peanut Allergy (Immunology) - Drugs In Development, 2021
US$ 2,000.00
Peanut Allergy (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provid...
July 2021
176 pages
Peritoneal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Peritoneal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Drugs In Development, 2021, pr...
July 2021
2212 pages
Polycythemia Vera (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Polycythemia Vera (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Drugs In Development, 2021, pr...
July 2021
142 pages
